# Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome

> **NCT06199544** · PHASE1 · UNKNOWN · sponsor: **Hamdard University** · enrollment: 150 (estimated)

## Conditions studied

- Comparative Study

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT06199544
- **Lead sponsor:** Hamdard University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06199544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06199544, "Effect of Unani Medicine for the Management of Anomalies Associated With Polycystic Ovarian Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06199544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*